Sempre Health, a behavior-based healthcare pricing platform, has closed a $15 million Series B funding round led by Blue Venture Fund, the Blue Cross Blue Shield Association, and Sandbox.
Additional investors such as UPMC Enterprises, Rethink Impact, LifeForce Capital, and Industry Ventures participated in the round as well.
Sempre offers patients discounts on their prescriptions when they refill them on time, with the hopes of improving medication adherence. The company partners with health plans and works with pharma manufacturers to give patients savings.
With the new funding, Sempre will build new partnerships with payers and pharma companies to expand its user base.
Want to publish your own articles on DistilINFO Publications?
Send us an email, we will get in touch with you.
Source: Mobihealthnews
